about
Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structuresReciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agentsAntidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonistOn the feasibility of designing new antidepressants.Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.An improved asymmetric synthetic route to a novel triple uptake inhibitor antidepressant (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol (D-142)Substrate and drug binding sites in LeuT.Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?Interaction of Na+, K+, and Cl- with the binding of amphetamine, octopamine, and tyramine to the human dopamine transporter.New antidepressants or more of the same?Dibenzylammonium hydrogen maleate and a redetermination at 120 K of bis(dibenzylamino)methane.Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity.Design, synthesis, and pharmacological evaluation of novel 2-(4-substituted piperazin-1-yl)1, 8 naphthyridine 3-carboxylic acids as 5-HT3 receptor antagonists for the management of depression.Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions.Hippocampal MicroRNAs Respond to Administration of Antidepressant Fluoxetine in Adult Mice.Recent advances in the identification of alpha1- and alpha2-adrenoceptor subtypes: therapeutic implications.Design, synthesis and evaluation of antidepressant activity of novel 2-methoxy 1, 8 naphthyridine 3-carboxamides as 5-HT3 receptor antagonists
P2860
Q24655640-ED6CA9AC-54A1-4915-859E-A6F25C5070C6Q28140526-90505DE1-1FB8-4334-8E01-54885C734A81Q28537732-E6F15D6F-180C-45E9-9D40-003AE9C55F15Q31116056-D7081ABF-8748-4C10-BDC7-E211607F2B79Q34464040-305D30F5-9512-420E-96FD-11D2858B0C60Q35209813-1ABB4B0C-4B23-482D-B6BE-22D74D37C6EBQ37782457-F69E1B06-7882-48E5-9338-B92ED5A8B6BCQ39127987-CCFC4180-CE47-4DC9-9155-53A306121294Q40891031-71403508-650E-4D11-B2FE-668A714C6765Q41877747-CF8FFC44-7C35-4167-8E79-374C01399653Q45716666-75C42613-7DD8-49B6-B129-73CF8317C11DQ48136147-5749277E-768B-4AAA-8D1E-FCCEBF53CC46Q48279199-8FAD5A0B-E5CE-47DE-AEEB-532443DBF497Q48309573-CCDE430F-A887-4A0F-B842-2B53FE96CC22Q50421340-36BCA64A-B7F3-428D-8E15-8E5E3534B0F6Q51544359-5DEFC2CC-A62C-42DD-B345-B0053DD57B76Q57097268-DAC4D19D-F60D-4616-97B3-23678D398E12
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Third-generation antidepressants.
@en
type
label
Third-generation antidepressants.
@en
prefLabel
Third-generation antidepressants.
@en
P2860
P356
P1476
Third-generation antidepressants.
@en
P2093
Wieringa JH
P2860
P304
P356
10.1002/MED.2610130304
P577
1993-05-01T00:00:00Z